Search results
PROMOTED
Start date:
Jun 10, 2026
Transcatheter edge-to-edge repair (TEER) is rapidly emerging as an important treatment option for patients with tricuspid regurgitation. Successful procedures require a detailed understanding of tricuspid valve anatomy, precise imaging guidance, and thoughtful procedural planning—especially in complex anatomies.This webinar brings together leading experts Prof Andrew Cook (UCL Institute…
View more
PROMOTED
Start date:
Jan 21, 2026
Pacemaker implantation remains one of the most common complications after TAVI. In this webinar, chaired by Prof Rafal Dworakowski (Abbott APAC Medical Affairs Director, Singapore, SG) and Dr Simon Lam (Queen Mary Hospital, Hong Kong, HK), leading specialists will focus on the anatomy of the conduction system anatomy, highlight key pre-procedural planning considerations, and share proven…
View more
Added:
5 months ago
Discover why tricuspid regurgitation aetiology matters for patient outcomes and intervention strategies with Prof Denisa MuraruThis presentation, part of a comprehensive series on complex cases in interventional cardiology, explores how understanding TR mechanisms directly impacts diagnosis, treatment selection, and clinical prognosis.Prof Muraru addresses the critical heterogeneity in TR…
View more
Drug-coated Balloon Angioplasty in Sri Lanka
Added:
6 months ago
Original Research
The Hybrid Approach in CAD with Restore® DEB
Video Series
Added:
11 months ago
Source:
Radcliffe Cardiology
AUTHOR: Ola WisniewskaA novel optical coherence tomography (OCT)-based physiological assessment, virtual flow reserve (VFR), has been shown to predict 2-year clinical outcomes following percutaneous coronary intervention (PCI), independent of anatomical measures like minimal stent area (MSA). This finding comes from a new substudy of the ILUMIEN IV trial, highlighting the potential of VFR to…
View more
Added:
2 weeks ago
EuroPCR 2026 – Prof Howard Herrmann (University of Pennsylvania School of Medicine, Philadelphia, PA, US) joins us to discuss three-year outcomes from the SMART trial, evaluating self-expanding versus balloon-expandable transcatheter aortic valve replacement in patients with a small aortic annulus and symptomatic severe native aortic stenosis.This prospective, international, randomised controlled…
View more
Added:
2 months ago
ACC 2026 — Drs Karim Al-Azizi (Baylor Scott & White The Heart Hospital, Plano) and Babar Basir (Henry Ford Hospital, US) deliver a short, front-line interventional view of the STEMI Door-to-Unload (STEMI-DTU) trial (NCT03000270), making this an efficient 5-minute update for cardiologists and cath lab teams.STEMI-DTU randomised haemodynamically stable patients aged 18–85 years with a first acute…
View more
Added:
11 months ago
New York Valves 2025 - Early outcomes from an observational study with the PASCAL System show a 97% device success rate.Dr Santiago Garcia (The Christ Hospital, Cincinnati, OH, US) joins us to discuss a novel TEER device system. This observational study investigated the use of the PASCAL Prescision system in over 2000 patients from the STS/ACC/TVT registry over a period of two years.Findings…
View more
Added:
7 months ago
TCT 25 - Dr Raj Makkar (Cedars-Sinai Medical Center, US) joins us to discuss the findings on the EVOQUE Valve (Edwards Lifesciences) drawing from data in the STS/ACC Transcatheter Valve Therapy Registry.The study evaluated procedural success rates, in-hospital complications, and 30-day clinical outcomes in patients undergoing transcatheter tricuspid valve replacement for severe tricuspid…
View more